Oxford University and drugmaker AstraZeneca say late-stage trials of their COVID-19 vaccine show it to be up to 90% effective, giving public health officials hope they may soon have access to a vaccine that is easier to distribute than some of its rivals. A half-dose of the vaccine followed by a full dose at least one month later was 90% effective, researchers reported Monday. No hospitalizations or severe cases of COVID-19 were reported in those receiving the vaccine, AstraZeneca said. Advertisement“These findings show that we have an effective vaccine that will save many lives. Two other drugmakers, Pfizer and Moderna, last week reported preliminary results from late-stage trials showing that their COVID-19 vaccines were almost 95% effective.

Source: Los Angeles Times November 23, 2020 07:50 UTC